In COVID-19 clinical update #107, Daniel Griffin reviews vaccine booster doses, at-home testing, transmission in hamsters, improving indoor air quality, trials of BCG, ivermectin, and fluvoxamine, vaccination during pregnancy, mRNA vaccines and Fc functions, anti-platelet and aspirin therapy and a trial of prone positioning.

链接：https://www.microbe.tv/twiv/twiv-883/?

Links for this episode

• FDA authorizes second booster (FDA) 2:37
• Second booster and mortality (Res Square) 4:38
• Booster effectiveness vs hospitalization (MMWR) 6:44
• SARS-CoV-2 coinfections (Lancet) 
• At-home testing (MMWR) 15:01
• Transmission study in hamsters (PLoS Path) 16:06
• Improving indoor air quality (EPA) 17:12
• BCG vaccine no effect on viral infections (Clin Inf Dis) 18:17
• Vaccination during pregnancy (JAMA) 19:30
• mRNA vaccines and different Fc functions (Sci Transl Med) 20:27
• Ivermectin clinical trial (NEJM) 23:36
• Fluvoxamine clinical trial (Lancet) 24:47
• Antiplatelet therapy (JAMA) 30:50
• Aspirin and in-hospital mortality (JAMA) 30:20
• Proning trial (Brit Med J) 31:39
• Contribute to ASTMH fundraiser at PWB 34:00
• Dr. Griffin’s treatment guide (pdf)
• Letters read on TWiV 883 34:38